secwatch.observer — SEC 8-K summary
======================================

Issuer:     ASSEMBLY BIOSCIENCES, INC. (ASMB)
CIK:        0001426800
Form:       8-K
Filed at:   2021-08-03T23:59:59+00:00
Accession:  0001564590-21-040208
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Assembly Biosciences promotes Okazaki to COO and Samar to CFO effective August 1
--------------------------------------------------------------------------------

- Jason Okazaki promoted to COO, retains Chief Legal and Business Officer roles; base salary $540,000, target bonus 55%.
- Michael Samar, previously acting principal financial officer, named CFO with base salary $400,000 and target bonus 40%.
- Both promotions effective August 1, 2021; employment agreements include change-in-control severance provisions.
- Okazaki and Samar were already serving as executive officers; no new director appointments or departures.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1426800/000156459021040208/0001564590-21-040208-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1426800/000156459021040208/asmb-8k_20210730.htm
  HTML page:      https://secwatch.observer/filing/0001564590-21-040208

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer